Literature DB >> 23812749

Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts.

Koji Tanabe1, Michiko Nakamura, Megumi Narita, Kazutoshi Takahashi, Shinya Yamanaka.   

Abstract

Pluripotency can be induced in somatic cells by forced expression of POU domain, class 5, transcription factor 1 (OCT3/4), sex determining region Y-box 2 (SOX2), Kruppel-like factor 4 (KLF4), myelocytomatosis oncogene (c-MYC) (OSKM). However, factor-mediated direct reprogramming is generally regarded as an inefficient and stochastic event. Contrary to this notion, we herein demonstrate that most human adult dermal fibroblasts initiated the reprogramming process on receiving the OSKM transgenes. Within 7 d, ~20% of these transduced cells became positive for the TRA-1-60 antigen, one of the most specific markers of human pluripotent stem cells. However, only a small portion (~1%) of these nascent reprogrammed cells resulted in colonies of induced pluripotent stem cells after replating. We found that many of the TRA-1-60-positive cells turned back to be negative again during the subsequent culture. Among the factors that have previously been reported to enhance direct reprogramming, LIN28, but not Nanog homeobox (NANOG), Cyclin D1, or p53 shRNA, significantly inhibited the reversion of reprogramming. These data demonstrate that maturation, and not initiation, is the limiting step during the direct reprogramming of human fibroblasts toward pluripotency and that each proreprogramming factor has a different mode of action.

Entities:  

Keywords:  ES cells; HDF; iPS cell; stemness; transcription factor

Mesh:

Year:  2013        PMID: 23812749      PMCID: PMC3725041          DOI: 10.1073/pnas.1310291110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Generation of pluripotent stem cells from adult mouse liver and stomach cells.

Authors:  Takashi Aoi; Kojiro Yae; Masato Nakagawa; Tomoko Ichisaka; Keisuke Okita; Kazutoshi Takahashi; Tsutomu Chiba; Shinya Yamanaka
Journal:  Science       Date:  2008-02-14       Impact factor: 47.728

2.  Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.

Authors:  Sarah Eminli; Jochen Utikal; Katrin Arnold; Rudolf Jaenisch; Konrad Hochedlinger
Journal:  Stem Cells       Date:  2008-07-17       Impact factor: 6.277

3.  Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells.

Authors:  Sarah Eminli; Adlen Foudi; Matthias Stadtfeld; Nimet Maherali; Tim Ahfeldt; Gustavo Mostoslavsky; Hanno Hock; Konrad Hochedlinger
Journal:  Nat Genet       Date:  2009-08-09       Impact factor: 38.330

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Linking the p53 tumour suppressor pathway to somatic cell reprogramming.

Authors:  Teruhisa Kawamura; Jotaro Suzuki; Yunyuan V Wang; Sergio Menendez; Laura Batlle Morera; Angel Raya; Geoffrey M Wahl; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

7.  Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

Authors:  Jacob Hanna; Styliani Markoulaki; Patrick Schorderet; Bryce W Carey; Caroline Beard; Marius Wernig; Menno P Creyghton; Eveline J Steine; John P Cassady; Ruth Foreman; Christopher J Lengner; Jessica A Dausman; Rudolf Jaenisch
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

8.  A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.

Authors:  Marius Wernig; Christopher J Lengner; Jacob Hanna; Michael A Lodato; Eveline Steine; Ruth Foreman; Judith Staerk; Styliani Markoulaki; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2008-07-01       Impact factor: 54.908

9.  Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.

Authors:  Jeong Beom Kim; Holm Zaehres; Guangming Wu; Luca Gentile; Kinarm Ko; Vittorio Sebastiano; Marcos J Araúzo-Bravo; David Ruau; Dong Wook Han; Martin Zenke; Hans R Schöler
Journal:  Nature       Date:  2008-06-29       Impact factor: 49.962

10.  Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells.

Authors:  P W Andrews; G Banting; I Damjanov; D Arnaud; P Avner
Journal:  Hybridoma       Date:  1984
View more
  52 in total

1.  Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.

Authors:  Jordan E Pomeroy; Shelley R Hough; Kathryn C Davidson; Alex M Quaas; Jordan A Rees; Martin F Pera
Journal:  Stem Cells Transl Med       Date:  2016-05-09       Impact factor: 6.940

Review 2.  Cell signalling pathways underlying induced pluripotent stem cell reprogramming.

Authors:  Kate Hawkins; Shona Joy; Tristan McKay
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

3.  Dppa3 is critical for Lin28a-regulated ES cells naïve-primed state conversion.

Authors:  Hui Sang; Dan Wang; Shuang Zhao; Jinxin Zhang; Yan Zhang; Jia Xu; Xiaoniao Chen; Yan Nie; Kaiyue Zhang; Shuaiqiang Zhang; Yuebing Wang; Na Wang; Fengxia Ma; Ling Shuai; Zongjin Li; Na Liu
Journal:  J Mol Cell Biol       Date:  2019-06-01       Impact factor: 6.216

Review 4.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

Review 5.  The cell cycle in stem cell proliferation, pluripotency and differentiation.

Authors:  Lijun Liu; Wojciech Michowski; Aleksandra Kolodziejczyk; Piotr Sicinski
Journal:  Nat Cell Biol       Date:  2019-09-02       Impact factor: 28.824

Review 6.  Regulatory factors of induced pluripotency: current status.

Authors:  Wei Zhao; Bo Ning; Chen Qian
Journal:  Stem Cell Investig       Date:  2014-07-22

7.  Tracking and Predicting Human Somatic Cell Reprogramming Using Nuclear Characteristics.

Authors:  Kaivalya Molugu; Ty Harkness; Jared Carlson-Stevermer; Ryan Prestil; Nicole J Piscopo; Stephanie K Seymour; Gavin T Knight; Randolph S Ashton; Krishanu Saha
Journal:  Biophys J       Date:  2019-10-22       Impact factor: 4.033

8.  Local Genome Topology Can Exhibit an Incompletely Rewired 3D-Folding State during Somatic Cell Reprogramming.

Authors:  Jonathan A Beagan; Thomas G Gilgenast; Jesi Kim; Zachary Plona; Heidi K Norton; Gui Hu; Sarah C Hsu; Emily J Shields; Xiaowen Lyu; Effie Apostolou; Konrad Hochedlinger; Victor G Corces; Job Dekker; Jennifer E Phillips-Cremins
Journal:  Cell Stem Cell       Date:  2016-05-05       Impact factor: 24.633

9.  Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.

Authors:  Mari Ohnuki; Koji Tanabe; Kenta Sutou; Ito Teramoto; Yuka Sawamura; Megumi Narita; Michiko Nakamura; Yumie Tokunaga; Masahiro Nakamura; Akira Watanabe; Shinya Yamanaka; Kazutoshi Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-05       Impact factor: 11.205

10.  The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes.

Authors:  Kathleen A Worringer; Tim A Rand; Yohei Hayashi; Salma Sami; Kazutoshi Takahashi; Koji Tanabe; Megumi Narita; Deepak Srivastava; Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2013-11-14       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.